Abstract
Introduction

58
It is well established that loss of ovarian function in women is associated with an increase 59 in fat mass, primarily in the region of the visceral organs, without large changes in overall weight 60 gain (13, 15, 26) . This effect extends to female animal models of reduced ovarian function (12, 61 20, 43) . Unlike diet-induced obesity, the accumulation of visceral fat mass after loss of ovarian 62 function is not entirely due to alterations in activity level or eating behaviors, and can occur 63 independent of age (15). The accumulation of visceral fat mass is strongly associated with 64 multiple deleterious metabolic conditions, including peripheral insulin resistance, cardiovascular
In women, circulating estrogens appear to play a critical role in defining the capacity to tissue function beyond 17β-estradiol (i.e. the dominant form of estrogen in circulation). Further, 106 current literature including 17β-estradiol supplementation provides 17β-estradiol at supra-107 physiological levels and does not mimic the cyclic nature of circulating 17β-estradiol. Some 108 studies using 17β-estradiol supplementation also demonstrate that 17β-estradiol does not fully 109 attenuate all consequences of the loss of functional ovaries (60). The experiments described here 110 will hopefully provide critical direction for investigators examining the role of female sex 111 steroids in the regulation of metabolic function.
112
Methods
113
Animals: Prior to beginning this study, all aspects were approved by the University of Maryland
114
Institutional Animal Care and Use Committee (IACUC) Review Board. Eight-ten week old 115 virgin female C57/BL6 mice were utilized in this study. The mice were divided into two groups:
116
SHAM and OVX, where OVX mice underwent bilateral ovariectomy and the SHAM group was 117 anaesthetized but ovaries were left intact. We have previously shown that OVX surgery results in 118 an approximate ~70% reduction in circulating estrogens within 48 hours (51). Loss of circulating 119 ovarian hormones due to ovariectomy was confirmed in OVX animals by a significant decrease in 120 uterine weights compared to SHAM animals (Table 1) . Utilizing uterine mass as indicator of 121 reduced estrogen function is employed since most methods for quantifying murine derived 122 estrogens are not considered accurate.
123
All mice were housed individually in a standard mouse cage in a temperature-controlled 124 room with a 12 hour light/dark cycle and were provided with ad libitum access to standard rodent 125 chow (Purina Laboratory Rodent Diet 5001: 23% protein, 4.5% fat, 6% fiber) and water. Unlike 126 rats, mice do not become hyperphagic in response to ovariectomy and were therefore 127 preferentially chosen as the animal model for this study (22, 34, 59 ). To confirm this finding,
128
food intake was measured in a separate cohort of age-matched animals, as previously described but without collagenase. FDB muscles were triturated with a small bore (~ 1mm) fire polished 155 glass transfer pipette to yield single FDB myofibers. Following trituration, large debris (nerve, 156 un-digested FDB muscle) was removed with forceps. The single fibers were then placed onto an 157 ECM coated glass bottom plate (MatTek, Ashland, MA) according to previously described 158 techniques (14) . Fibers were allowed to adhere, rinsed with Ringer buffer to remove all media,
159
and stained for 30 mins with BODIPY 493/503 and 4,6-diamidino-2-phenylindole (DAPI) to 160 label myonuclei (Invitrogen, Cambridge, MA) (14). After 30 minutes, the dyes were removed by 161 rinsing fibers 3X with fresh Ringer buffer. Fibers were imaged using a Zeiss AxioObserver Z1 162 fluorescent microscope (Carl Zeiss MicroImaging, Jena, Germany).
163
Immunoblot procedures: Plantaris muscles were used to determine the protein content of
164
CD36/FAT and FATPpm in the SHAM and OVX mice according to previously described 165 methods (3). The soleus muscle was not used because we were unable to extract a sufficient 166 amount of total protein to reliably measure the CD36/FAT or FATPpm. Muscles were 167 homogenized, proteins separated by SDS-PAGE and the transporters were detected through 168 immunoblotting using antibodies specific for CD36/FAT or FATPpm as previously described (3).
169
Equal quantities of total protein were loaded (20 μg) on each gel and Ponceau S staining on the 170 membranes was used to confirm equal loading.
171
Mitochondria Isolation and Immunoblot Procedure: Mitochondria were isolated from 172 gastrocnemius muscles from SHAM and OVX muscles as previously described (10). Isolated 173 mitochondria were used to determine the protein content of mitochondrial enzymes very long 174 chain, long chain, and medium chain acyl CoA dehydrogenases (VLCAD, LCAD, MCAD) and 175 mitochondrial complexes I-V as previously described (23, 26, 31, 45 
239
OVX were due to increased LD frequency within the myoplasm and not between the muscle 240 fibers (Fig 2B) . In the SHAM animals, we found very few LD within the isolated single muscle 241 fibers (Fig 2B) . 
262
to the SHAM animals (25, 53, 56) . Surprisingly, we found total LC species to be reduced in the
263
OVX group compared to the SHAM group ( Figure 4A ). No differences in medium chain (MC) 264 acylcarnitines were identified ( Figure 4B ), but we did detect significantly lower levels of short 265 chain (SC) acylcarnitines in the OVX group compared to the SHAM group ( Figure 4C ). These 266 data suggest a reduced flux through the β-oxidation pathway in the muscle from the OVX group 267 compared to the SHAM group. Coupled with the reduction in acylcarnitines, we determined that 268 skeletal muscle free carnitine levels were significantly lower (p < 0.05) in OVX mice compared 269 to SHAM mice ( Figure 4D ). A number of previous publications have found that a reduction in 270 free carnitine levels correlates with decreases in skeletal muscle lipid metabolism (24, 42, 58) .
271
Collectively, these data imply that reductions in flux through β-oxidation could contribute to a 
281
Glycolytic and TCA cycle metabolites: Previous data in other models of obesity have shown that 282 accumulation of LC-acylcarnitines species was associated with a significant reduction in Krebs 283 cycle intermediates, reflecting a form of mitochondrial dysfunction. We found no differences in 284 either pyruvate or lactate levels between OVX and SHAM animals ( Figure 6A ). However, citrate 285 and succinate levels were significantly (p < 0.05) higher in skeletal muscle from OVX compared 
292
Therefore, we evaluated the skeletal muscle amino acid profile in the OVX mice compared to the 293 SHAM mice (Figure 7A-D) . In OVX mice, we identified significant decreases in the BCAAs, 294 leucine and isoleucine, however there was no significant difference in valine as compared to 295 SHAM mice (p < 0.05) ( Figure 7B ,C). We also found significant decreases in the concentrations 296 of alanine, glutamine/glutamic acid, proline, serine, and histidine in OVX mice compared to 297 SHAM ( Figure 7A ,B,C).
298
Odd Chain Acyl-Carnitine Species: Odd chain acyl-carnitine species propionylcarnitine (C3), 299 isovalerylcarnitine (C5), and tiglyl carnitine (C5:1) are products of BCAA catabolism (32, 38).
300
Due to the observed decline in skeletal muscle amino acids in OVX mice, we measured C3, C5,
301
and C5:1 species in SHAM and OVX mice. We detected a reduction in C3 species in OVX mice compared to SHAM (p<0.05) and no difference in C5 species (Figure 8 ). However, we observed 303 a reduction in the unsaturated C5:1 acyl-carnitine species (p<0.05) (Figure 8 
318
Pyruvate stimulated normalized OCR was increased from baseline in both OVX and SHAM, 319 however, there was no significant difference between the OVX and SHAM groups ( Figure 9C ).
320
To assess substrate specific maximal ETC activity, we added the uncoupling agent, FCCP, and 
347
Consistent with other studies, we found that ovariectomy resulted in significant increases 
360
Due to the metabolic complexity of skeletal muscle, we employed a targeted metabolic 361 profiling approach to generate a comprehensive non-bias analysis of skeletal muscle in the 362 SHAM and OVX groups (25). Since the OVX group exhibited significant increases in adiposity 363 coupled with high IMCL, we hypothesized that, in a similar fashion to other obesity models
364
(29,33), we would find substantial increases in LC in the OVX group compared to the SHAM 365 group. Surprisingly, we found relative decreases in the LC levels in the OVX, which could 366 suggest impaired transport of LCFA into the mitochondria. The enzyme CPT-1 combines 367 cytosolic free carnitine with long chain fatty acids, producing an acyl-carnitine that is then 368 transported into the mitochondria (6). CPT-1 activity is reduced through allosteric inhibition by 369 malonyl CoA and a lack of free carnitine (20, 24, 58) . Therefore, because we detected no 370 differences in malonyl CoA levels or CPT-1 mRNA levels, but did detect a reduction in free 371 carnitine levels in the OVX group, we suspect that transport of LCFA into the mitochondria via (11, 30, 55) . However, we found no differences in the mitochondrial Based on our data it seems critical to measure SCAD as well, however we were unable to obtain (41) . Surprisingly, we found that concentrations of the majority of amino acids were significantly differences tending to decrease in the OVX group. The decreases in amino acid levels may 427 suggest enhanced metabolic amino acid catabolism or a loss of the available amino acid pool.
428
The former is a perplexing finding, since we detected decreases in odd-chain acetylcarnitine 
438
However, this hypothesis would need to be further tested.
439
Potential Limitations: It should be noted that using the metabolic profiling approach 
447
Since estrogens affect multiple tissues, it is difficult to assess which effects are a direct result of 448 reduced estrogen levels and which are secondary effects due to changes in other non-skeletal 449 muscle tissues. It is critical to develop experimental models to specifically isolate estrogen signaling in skeletal muscle to determine the primary role for estrogens in skeletal muscle 451 metabolism.
452
Overall, utilization of the metabolic profiling approach in the OVX model demonstrates 
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N=6 animals/group. * indicates significantly differs from SHAM (p<0.05).
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Figure 9 (A-E):
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